Wayne, Pa.-based Shire’s $2.6 billion acquisition of New River Pharmaceuticalswill mean one less biotechnology company in Virginia.
Pharmaceutical giant Shire announced the acquisition Tuesday and plans to have the deal finalized in the second quarter of this year, Shire spokesman Matt Cabrey said.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.